CD133-redirected chimeric antigen receptor engineered autologous T-cel
- This topic has 0 replies, 1 voice, and was last updated 7 years, 2 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
CD133-redirected chimeric antigen receptor engineered autologous T-cell treatment in patients with advanced and metastatic malignancies.
http://abstracts.asco.org/199/AbstView_199_181682.html
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.